While early studies questioned the efficacy of oral glutathione, more recent, rigorous clinical trials have proven that high-dose, long-term supplementation can profoundly impact cellular health
64,65 Tumors may also evade immune surveillance by downregulating tumor-associated antigens (TAAs), selecting for neoantigen-depleted clones, or upregulating alternative inhibitory checkpoints, as observed in EGFR-mutant non-small cell lung cancer (NSCLC) following targeted therapy
Unlike IGF-1 DES, which benefits from site-specific injection, LR3's long half-life means injection site matters less, the peptide will circulate systemically regardless of where you inject it
However, both work in different ways, which leaves the users questioning which is the most effective option to choose